20 related articles for article (PubMed ID: 38760477)
1. False-Positive Human Immunodeficiency Virus Nucleic Acid Amplification Test After Chimeric Antigen Receptor T-Cell Therapy With Ciltacabtagene Autoleucel.
Keri VC; Topulli MV; Deol A; Uberti J; Salimnia H; Chandrasekar PH
Open Forum Infect Dis; 2024 Jan; 11(1):ofad633. PubMed ID: 38288349
[TBL] [Abstract][Full Text] [Related]
2. False-Positive Results for Human Immunodeficiency Virus Type 1 Nucleic Acid Amplification Testing in Chimeric Antigen Receptor T Cell Therapy.
Hauser JR; Hong H; Babady NE; Papanicolaou GA; Tang YW
J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31694968
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of 4-1BB-costimulated HER2-targeted chimeric antigen receptor T cell therapy for synovial sarcoma.
Murayama Y; Kawashima H; Kubo N; Shin C; Kasahara Y; Imamura M; Oike N; Ariizumi T; Saitoh A; Mihara K; Umezu H; Ogose A; Imai C
Transl Oncol; 2021 Dec; 14(12):101227. PubMed ID: 34555727
[TBL] [Abstract][Full Text] [Related]
4. NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcoma.
Murayama Y; Kasahara Y; Kubo N; Shin C; Imamura M; Oike N; Ariizumi T; Saitoh A; Baba M; Miyazaki T; Suzuki Y; Ling Y; Okuda S; Mihara K; Ogose A; Kawashima H; Imai C
Transl Oncol; 2022 Nov; 25():101521. PubMed ID: 35998437
[TBL] [Abstract][Full Text] [Related]
5. PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapy.
Luk SJ; van der Steen DM; Hagedoorn RS; Jordanova ES; Schilham MW; Bovée JV; Cleven AH; Falkenburg JF; Szuhai K; Heemskerk MH
Oncoimmunology; 2018; 7(12):e1507600. PubMed ID: 30524904
[TBL] [Abstract][Full Text] [Related]
6. Wild-type HIV infection after treatment with lentiviral gene therapy for β-thalassemia.
Hongeng S; Anurathapan U; Songdej D; Phuphuakrat A; Jongrak K; Parsons G; Deary B; Bonner M; Veres G; Asmal M
Blood Adv; 2021 Jul; 5(13):2701-2706. PubMed ID: 34196676
[TBL] [Abstract][Full Text] [Related]
7. CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
Wagner J; Wickman E; DeRenzo C; Gottschalk S
Mol Ther; 2020 Nov; 28(11):2320-2339. PubMed ID: 32979309
[TBL] [Abstract][Full Text] [Related]
8. Prevention of transfusion-transmitted infections.
Busch MP; Bloch EM; Kleinman S
Blood; 2019 Apr; 133(17):1854-1864. PubMed ID: 30808637
[TBL] [Abstract][Full Text] [Related]
9. Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1
D'Angelo SP; Melchiori L; Merchant MS; Bernstein D; Glod J; Kaplan R; Grupp S; Tap WD; Chagin K; Binder GK; Basu S; Lowther DE; Wang R; Bath N; Tipping A; Betts G; Ramachandran I; Navenot JM; Zhang H; Wells DK; Van Winkle E; Kari G; Trivedi T; Holdich T; Pandite L; Amado R; Mackall CL
Cancer Discov; 2018 Aug; 8(8):944-957. PubMed ID: 29891538
[TBL] [Abstract][Full Text] [Related]
10. False-positive results with select HIV-1 NAT methods following lentivirus-based tisagenlecleucel therapy.
Laetsch TW; Maude SL; Milone MC; Davis KL; Krueger J; Cardenas AM; Eldjerou LK; Keir CH; Wood PA; Grupp SA
Blood; 2018 Jun; 131(23):2596-2598. PubMed ID: 29669777
[No Abstract] [Full Text] [Related]
11. Clinical use of lentiviral vectors.
Milone MC; O'Doherty U
Leukemia; 2018 Jul; 32(7):1529-1541. PubMed ID: 29654266
[TBL] [Abstract][Full Text] [Related]
12. Absence of Replication-Competent Lentivirus in the Clinic: Analysis of Infused T Cell Products.
Cornetta K; Duffy L; Turtle CJ; Jensen M; Forman S; Binder-Scholl G; Fry T; Chew A; Maloney DG; June CH
Mol Ther; 2018 Jan; 26(1):280-288. PubMed ID: 28970045
[TBL] [Abstract][Full Text] [Related]
13. Gene Therapy with the Sleeping Beauty Transposon System.
Kebriaei P; Izsvák Z; Narayanavari SA; Singh H; Ivics Z
Trends Genet; 2017 Nov; 33(11):852-870. PubMed ID: 28964527
[TBL] [Abstract][Full Text] [Related]
14. False-positive HIV nucleic acid amplification testing during CAR T-cell therapy.
Ariza-Heredia EJ; Granwehr BP; Viola GM; Bhatti M; Kelley JM; Kochenderfer J; Hosing C
Diagn Microbiol Infect Dis; 2017 Aug; 88(4):305-307. PubMed ID: 28610774
[TBL] [Abstract][Full Text] [Related]
15. Estimating per-act HIV transmission risk: a systematic review.
Patel P; Borkowf CB; Brooks JT; Lasry A; Lansky A; Mermin J
AIDS; 2014 Jun; 28(10):1509-19. PubMed ID: 24809629
[TBL] [Abstract][Full Text] [Related]
16. False-positive HIV PCR test following ex vivo lentiviral gene transfer treatment of X-linked severe combined immunodeficiency vector.
De Ravin SS; Gray JT; Throm RE; Spindler J; Kearney M; Wu X; Coffin JM; Hughes SH; Malderelli F; Sorrentino BP; Malech HL
Mol Ther; 2014 Feb; 22(2):244-245. PubMed ID: 24487563
[No Abstract] [Full Text] [Related]
17. False-positive human immunodeficiency virus nuclear acid amplification technique testing following therapy with transgenic T cell receptor cellular therapy for synovial sarcoma.
Slade M; Araujo D; Du M; Parikh B; Anderson N; Van Tine BA; Ghobadi A
Bone Marrow Transplant; 2024 May; ():. PubMed ID: 38760477
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
